Spotless Management

Results

107

20 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

107 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MSFT	US$451.10	18.2%	-15.4%	US$2.9t	US$561.58	25.0	14.0%	0.8%	Software
	2330	NT$2,425.00	3.2%	112.7%	NT$57.2t	NT$3,117.26	28.4	21.2%	0.9%	Semiconductors
	A005930	₩266,000.00	6.6%	286.1%	₩1316.6t	₩479,814.50	11.7	31.5%	0.9%	Tech
	300750 New	CN¥395.30	3.2%	50.3%	CN¥1.9t	CN¥564.17	21.4	16.4%	2.1%	Capital Goods
	AZN	UK£127.20	0.3%	12.3%	UK£197.3b	UK£159.11	25.4	13.8%	1.9%	Pharmaceuticals & Biotech
	TXN New	US$278.76	-0.3%	54.1%	US$254.6b	US$324.45	42.3	17.1%	2.0%	Semiconductors
	SAP	€155.92	21.5%	-37.8%	€179.5b	€201.55	23.1	11.5%	1.6%	Software
	AIR New	€204.00	-0.2%	15.9%	€161.5b	€222.91	27.2	14.7%	1.6%	Capital Goods
	GILD	US$131.28	0.3%	16.9%	US$164.8b	US$157.15	17.7	20.3%	2.5%	Pharmaceuticals & Biotech
	GLW New	US$135.22	-13.4%	113.8%	US$106.9b	US$193.40	61.3	28.3%	0.8%	Tech
	CMI	US$632.98	-4.8%	72.2%	US$83.6b	US$754.86	32.7	17.6%	1.3%	Capital Goods
	4519	JP¥6,932.00	-6.5%	-5.6%	JP¥11.6t	JP¥9,686.67	24.2	12.2%	1.9%	Pharmaceuticals & Biotech
	RHM	€1,139.60	12.1%	-34.3%	€53.0b	€1,697.85	50.5	30.6%	1.0%	Capital Goods
	HO	€243.30	2.1%	3.2%	€50.0b	€292.67	33.4	16.3%	1.6%	Capital Goods
	603259	CN¥128.43	2.7%	38.1%	CN¥373.5b	CN¥150.47	20.1	11.1%	1.5%	Pharmaceuticals & Biotech
	STLD	US$252.50	2.2%	106.3%	US$36.2b	US$272.38	22.5	17.2%	0.8%	Materials
	600183 New	CN¥105.64	-11.0%	157.7%	CN¥243.1b	CN¥137.08	65.3	28.6%	1.5%	Tech
	EXPN	UK£28.98	9.2%	-27.6%	UK£25.6b	UK£37.15	23.0	10.0%	1.8%	Commercial Services
	992	HK$23.86	-2.0%	136.2%	HK$269.7b	HK$28.73	19.7	20.1%	1.8%	Tech
	FSR	R97.45	1.6%	28.5%	R542.4b	R105.48	12.3	15.9%	5.3%	Diversified Financials
	HAL	₹4,646.50	1.6%	4.7%	₹3.1t	₹5,165.96	34.1	12.3%	1.0%	Capital Goods
	BAP	US$402.27	3.8%	69.7%	US$30.5b	US$404.47	2.7	13.1%	3.7%	Banks
	500049 New	₹387.80	-4.3%	2.9%	₹2.8t	₹489.61	46.1	14.2%	0.6%	Capital Goods
	2327	NT$502.00	-21.8%	272.5%	NT$938.7b	NT$1,110.38	39.5	26.7%	1.2%	Tech

Page 1 of 3